Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 148
Filter
2.
Braz J Med Biol Res ; 56: e12647, 2023.
Article in English | MEDLINE | ID: mdl-37585915

ABSTRACT

DiGeorge syndrome is a disorder caused by a microdeletion on the long arm of chromosome 22. Approximately 1% of patients diagnosed with DiGeorge syndrome may have an absence of a functional thymus, which characterizes the complete form of the syndrome. These patients require urgent treatment to reconstitute T cell immunity. Thymus transplantation is a promising investigational procedure for reconstitution of thymic function in infants with congenital athymia. Here, we demonstrate a possible optimization of the preparation of thymus slices for transplantation through prior depletion of thymocytes and leukocyte cell lineages followed by cryopreservation with cryoprotective media (5% dextran FP 40, 5% Me2SO, and 5% FBS) while preserving tissue architecture. Thymus fragments were stored in liquid nitrogen at -196°C for 30 days or one year. The tissue architecture of the fragments was preserved, including the distinction between medullary thymic epithelial cells (TECs), cortical TECs, and Hassall bodies. Moreover, depleted thymus fragments cryopreserved for one year were recolonized by intrathymic injections of 3×106 thymocytes per mL, demonstrating the capability of these fragments to support T cell development. Thus, this technique opens up the possibility of freezing and storing large volumes of thymus tissue for immediate transplantation into patients with DiGeorge syndrome or atypical (Omenn-like) phenotype.


Subject(s)
DiGeorge Syndrome , Immunologic Deficiency Syndromes , Humans , Thymocytes , DiGeorge Syndrome/therapy , Thymus Gland , Epithelial Cells
3.
Braz. j. med. biol. res ; 56: e12647, 2023. graf
Article in English | LILACS-Express | LILACS | ID: biblio-1505885

ABSTRACT

DiGeorge syndrome is a disorder caused by a microdeletion on the long arm of chromosome 22. Approximately 1% of patients diagnosed with DiGeorge syndrome may have an absence of a functional thymus, which characterizes the complete form of the syndrome. These patients require urgent treatment to reconstitute T cell immunity. Thymus transplantation is a promising investigational procedure for reconstitution of thymic function in infants with congenital athymia. Here, we demonstrate a possible optimization of the preparation of thymus slices for transplantation through prior depletion of thymocytes and leukocyte cell lineages followed by cryopreservation with cryoprotective media (5% dextran FP 40, 5% Me2SO, and 5% FBS) while preserving tissue architecture. Thymus fragments were stored in liquid nitrogen at -196°C for 30 days or one year. The tissue architecture of the fragments was preserved, including the distinction between medullary thymic epithelial cells (TECs), cortical TECs, and Hassall bodies. Moreover, depleted thymus fragments cryopreserved for one year were recolonized by intrathymic injections of 3×106 thymocytes per mL, demonstrating the capability of these fragments to support T cell development. Thus, this technique opens up the possibility of freezing and storing large volumes of thymus tissue for immediate transplantation into patients with DiGeorge syndrome or atypical (Omenn-like) phenotype.

4.
Horm Metab Res ; 47(9): 656-61, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25985323

ABSTRACT

DAX1 transcription factor is a key determinant of adrenogonadal development, acting as a repressor of SF1 targets in steroidogenesis. It was recently demonstrated that DAX1 regulates pluripotency and differentiation in murine embryonic stem cells. In this study, we investigated DAX1 expression in adrenocortical tumors (ACTs) and correlated it with SF1 expression and clinical parameters. DAX1 and SF1 protein expression were assessed in 104 ACTs from 34 children (25 clinically benign and 9 malignant) and 70 adults (40 adenomas and 30 carcinomas). DAX1 gene expression was studied in 49 ACTs by quantitative real-time PCR. A strong DAX1 protein expression was demonstrated in 74% (25 out of 34) and 24% (17 out of 70) of pediatric and adult ACTs, respectively (χ(2)=10.1, p=0.002). In the pediatric group, ACTs with a strong DAX1 expression were diagnosed at earlier ages than ACTs with weak expression [median 1.2 (range, 0.5-4.5) vs. 2.2 (0.9-9.4), p=0.038]. DAX1 expression was not associated with functional status in ACTs. Interestingly, a positive correlation was observed between DAX1 and SF1 protein expression in both pediatric and adult ACTs (r=0.55 for each group separately; p<0.0001). In addition, DAX1 gene expression was significantly correlated with SF1 gene expression (p<0.0001, r=0.54). In conclusion, DAX1 strong protein expression was more frequent in pediatric than in adult ACTs. Additionally, DAX1 and SF1 expression positively correlated in ACTs, suggesting that these transcription factors might cooperate in adrenocortical tumorigenesis.


Subject(s)
Adrenal Cortex Neoplasms/metabolism , Carcinogenesis/metabolism , DAX-1 Orphan Nuclear Receptor/metabolism , Steroidogenic Factor 1/metabolism , Adrenal Cortex Neoplasms/genetics , Adrenocortical Adenoma/genetics , Adrenocortical Adenoma/metabolism , Adrenocortical Carcinoma/genetics , Adrenocortical Carcinoma/metabolism , Adult , Carcinogenesis/genetics , Child , Child, Preschool , DAX-1 Orphan Nuclear Receptor/genetics , Female , Gene Expression , Humans , Infant , Male , Middle Aged , Steroidogenic Factor 1/genetics
6.
Prenat Diagn ; 32(9): 897-902, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22777688

ABSTRACT

OBJECTIVE: The aim was to determine the outcome of pregnancies complicated by maternal Parvovirus B19 (B19) infection. METHOD: Among 175 pregnant women referred to our clinic because of suspicion of a B19 infection, 63 with confirmed laboratory diagnosis of acute/recent B19 infection were followed up by ultrasound and Doppler measurement of the middle cerebral artery peak systolic velocity. RESULTS: The vertical transmission rate was 31.7% (20/63). Of the 20 infected, 8 had hydrops, 1 had signs suggestive of meconium peritonitis and 1 had an isolated hydrothorax. Three fetuses presenting with hydrops were treated with intrauterine blood transfusion. Two of them died while the last showed resolution of anemia. Among the five untreated hydropic fetuses, one presented with mild signs that resolved spontaneously, two died at 16 and 17 weeks of gestation and two had also cardiomegaly and the parents opted for elective termination of pregnancy. All the anemic fetuses had middle cerebral artery peak systolic velocity values more than 1.8 multiples of the median. No stillbirth occurred. CONCLUSIONS: The outcome of uncomplicated cases with B19 infection is good. In the presence of hydrops prognosis was very poor. It seems therefore logical to attempt to pick up this ominous signs early.


Subject(s)
Fetal Diseases/etiology , Infant, Newborn, Diseases/etiology , Infectious Disease Transmission, Vertical , Parvoviridae Infections/transmission , Parvovirus B19, Human , Adult , Female , Fetal Diseases/epidemiology , Fetal Diseases/therapy , Gestational Age , Humans , Infant, Newborn , Infant, Newborn, Diseases/epidemiology , Infant, Newborn, Diseases/therapy , Infectious Disease Transmission, Vertical/statistics & numerical data , Parvoviridae Infections/complications , Parvoviridae Infections/epidemiology , Parvoviridae Infections/therapy , Parvovirus B19, Human/physiology , Pregnancy , Pregnancy Complications, Infectious/epidemiology , Pregnancy Complications, Infectious/therapy , Pregnancy Outcome/epidemiology , Retrospective Studies , Young Adult
7.
Rev Sci Instrum ; 83(12): 125101, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23282107

ABSTRACT

At the fusion experiment JET, a Michelson interferometer is used to measure the spectrum of the electron cyclotron emission in the spectral range 70-500 GHz. The interferometer is absolutely calibrated using the hot/cold technique and, in consequence, the spatial profile of the plasma electron temperature is determined from the measurements. The current state of the interferometer hardware, the calibration setup, and the analysis technique for calibration and plasma operation are described. A new, full-system, absolute calibration employing continuous data acquisition has been performed recently and the calibration method and results are presented. The noise level in the measurement is very low and as a result the electron cyclotron emission spectrum and thus the spatial profile of the electron temperature are determined to within ±5% and in the most relevant region to within ±2%. The new calibration shows that the absolute response of the system has decreased by about 15% compared to that measured previously and possible reasons for this change are presented. Temperature profiles measured with the Michelson interferometer are compared with profiles measured independently using Thomson scattering diagnostics, which have also been recently refurbished and recalibrated, and agreement within experimental uncertainties is obtained.

8.
Curr Med Res Opin ; 27(3): 569-78, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21222568

ABSTRACT

BACKGROUND: The PATER study assessed the frequency of high-risk (HR) and low-risk (LR) human papillomavirus (HPV) in HPV-induced lesions in patients with borderline cytology. METHODS: This retrospective observational cohort study was designed to evaluate ASCUS patients detected through a local cervical cancer screening programme and referred to the Department of Gynaecology and Obstetrics at the S. Orsola-Malpighi University Hospital in Bologna, in the period between January 2000 and December 2007. RESULTS: In 1047 patients aged 38.4 ± 9.6 years (range 23-65 years), 34.8% (n = 364) was positive for HR- or LR-HPV DNA. The mean age of women with HPV infection was significantly lower compared with the negative group (36.8 ± 9.4 versus 39.3 ± 9.6 years; p < 0.001). Overall, 357 (34.1%) women had cervical lesions: 279 (26.6%) had CIN1, 18 (1.7%) CIN2, and 60 (5.7%) CIN3+. HR-HPV genotype was detected in 83.3%, and 91.5% of patients with CIN2 and CIN3+ respectively. Among the 124 CIN1 HPV-positive women, 8.9% harboured LR-HPV genotypes, 80.6% HR-HPV and 10.5% a combination of HR- and LR-HPV. HPV-6 and 11 accounted for 19.4% of all HPV-positive CIN1 lesions. CONCLUSION: Our study suggest that: in ASCUS patients over 40 years there is a low risk of positivity for HPV infection; the HPV DNA testing in patients with CIN3+ and a mean age close to 40 years is highly sensitive (98.3%) and acceptably specific (75.5%); the frequency of LR-HPV (alone or in combination with HR) in ASCUS cytology is not negligible. A tetravalent-based HPV vaccination alongside the screening programme would provide considerable clinical, organizational, and economic benefits.


Subject(s)
Hepatitis B/complications , Hepatitis B/epidemiology , Uterine Cervical Diseases/epidemiology , Uterine Cervical Diseases/etiology , Vaginal Smears/statistics & numerical data , Adult , Aged , Algorithms , Cohort Studies , Female , Geography , Hepatitis B/diagnosis , Hepatitis B virus/physiology , Humans , Incidence , Italy/epidemiology , Middle Aged , Population , Reference Values , Uterine Cervical Diseases/diagnosis , Vaginal Smears/standards , Young Adult
9.
Dermatology ; 220(2): 138-42, 2010.
Article in English | MEDLINE | ID: mdl-20110633

ABSTRACT

BACKGROUND: Parvovirus B19 is the aetiological agent of erythema infectiosum. The presence of B19 DNA in lesional skin of other cutaneous manifestations has frequently been reported although there is disagreement on the role of the B19 virus in tissues. OBJECTIVES: To investigate the presence of B19 DNA (1) in skin lesions of patients with a described B19-related disease, (2) in skin lesions of B19-unrelated diseases and (3) in healthy skin. METHODS: A total of 121 skin samples were examined for the presence of B19 DNA by PCR assays and peptide-nucleic-acid-based in situ hybridisation techniques. RESULTS: B19 DNA was detected in 11/38 (28.9%) pityriasis lichenoides, 8/30 (26.7%) melanocytic naevi, 5/29 (17.2%) primary melanomas and 6/24 (25.0%) healthy skin biopsies. A difference in B19 DNA prevalence was observed in specimens grouped according to age, irrespective of pathologies. CONCLUSIONS: B19 DNA can be found in skin tissues of patients with pityriasis lichenoides as well as in lesions not related to B19 infection and in healthy controls. B19 DNA can be detected in skin of young subjects in a significantly high rate compared to adults, suggesting that viral persistence may be the usual outcome after primary infection.


Subject(s)
Erythema Infectiosum/virology , Parvovirus B19, Human/isolation & purification , Skin/virology , Adult , Aged , Aged, 80 and over , DNA, Viral/analysis , Female , Humans , Male , Melanoma/virology , Middle Aged , Nevus/virology , Pityriasis Lichenoides/virology , Skin Neoplasms/virology
10.
Anticancer Res ; 29(8): 3365-8, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19661357

ABSTRACT

OBJECTIVE: To investigate the possible role of chromatin texture parameters, nuclear morphology, DNA ploidy and clinical functional status in discriminating benign from malignant adrenocortical tumors (ACT). PATIENTS AND METHODS: Forty-eight cases of clinically benign (n=40) and clinically malignant (n=8) ACT with a minimum of 5-years' follow-up were evaluated for chromatin texture parameters (run length, standard deviation, configurable run length, valley, slope, peak and other 21 Markovian features that describe the distribution of the chromatin in the nucleus), nuclear morphology (nuclear area, nuclear perimeter, nuclear maximum and minimum diameter, nuclear shape), and DNA ploidy. Nuclear parameters were evaluated in Feulgen-stained 5 mum paraffin-sections analyzed using a CAS 200 image analyzer. RESULTS: Since ACTs present different biological features in children and adults, patients were divided into two groups: children (< or = 15 years) and adults (>15 years). In the group of children DNA ploidy presented a marginal significance (p=0.05) in discriminating ACTs. None of the parameters discriminated between malignant and benign ACT in the adult group. CONCLUSION: ACTs are uncommon and definitive predictive criteria for malignancy remain uncertain, particularly in children. Our data point to DNA content evaluated by image analysis as a new candidate tool for this challenging task. Texture image analysis did not help to differentiate malignant from benign adrenal cortical tumors in children and adults.


Subject(s)
Adrenal Cortex Neoplasms/genetics , Adrenal Cortex Neoplasms/pathology , Cell Nucleus/pathology , Chromatin/chemistry , Chromatin/genetics , Image Processing, Computer-Assisted , Adolescent , Adrenal Cortex Neoplasms/classification , Adult , Child , Child, Preschool , Humans , Infant , Ki-67 Antigen/metabolism , Middle Aged , Ploidies , Young Adult
11.
BJOG ; 116(6): 813-7, 2009 May.
Article in English | MEDLINE | ID: mdl-19432570

ABSTRACT

OBJECTIVE: The purpose of our work was to examine the most reliable laboratory diagnosis of fetal parvovirus B19 infection in hydropic fetuses by evaluating the most appropriate clinical sample and laboratory test. DESIGN: B19 DNA detection in fetal samples and serological signs of B19 infection in the respective mothers. Samples collected between January 2000 and July 2008. SETTING: Microbiology, University of Bologna, Bologna, Italy. SAMPLES: One hundred thirty-five fetal samples (58 fetal cord blood and 77 amniotic fluid samples) and 109 serum samples collected from 109 pregnant women. METHODS: Validated and certified in situ hybridisation assay (ISH) and polymerase chain reaction-enzyme-linked immunosorbent assay (PCR-ELISA) were performed on fetal samples to detect B19 DNA. B19-specific antibodies were investigated in maternal serum samples by a commercial enzyme immunoassay. MAIN OUTCOME MEASURES: Parvovirus B19 DNA detection in fetal specimens was analysed in relation to maternal serological signs of infection. RESULTS: Parvovirus B19 DNA was detected in 22.41% of fetal cord blood and 36.36% of amniotic fluid samples. A statistically significant difference was found between DNA detection by ISH (23.70%) and PCR-ELISA (14.81%) (P= 0.004). Only 11.76% of fetuses with virological diagnosis of B19 infection were from women with serological signs of acute/recent B19 infection. CONCLUSIONS: Diagnosis of fetal parvovirus B19 infection cannot always rely on maternal serological investigations but rather on the virological analysis of fetal samples. Both fetal cord blood and amniotic fluid samples are suitable for diagnosis, but the detection of B19 DNA in the cells of amniotic fluid samples by ISH proved to be the most reliable diagnostic system.


Subject(s)
Fetal Diseases/diagnosis , Parvoviridae Infections/diagnosis , Parvovirus B19, Human/isolation & purification , Prenatal Diagnosis/methods , Amniotic Fluid/virology , DNA, Viral/analysis , Enzyme-Linked Immunosorbent Assay/methods , Female , Fetal Blood/virology , Humans , Hydrops Fetalis/virology , In Situ Hybridization/methods , Parvovirus B19, Human/genetics , Polymerase Chain Reaction/methods , Pregnancy
12.
Arch Virol ; 153(4): 783-821, 2008.
Article in English | MEDLINE | ID: mdl-18256781

ABSTRACT

Geminivirus taxonomy and nomenclature is growing in complexity with the number of genomic sequences deposited in sequence databases. Taxonomic and nomenclatural updates are published at regular intervals (Fauquet et al. in Arch Virol 145:1743-1761, 2000, Arch Virol 148:405-421, 2003). A system to standardize virus names, and corresponding guidelines, has been proposed (Fauquet et al. in Arch Virol 145:1743-1761, 2000). This system is now followed by a large number of geminivirologists in the world, making geminivirus nomenclature more transparent and useful. In 2003, due to difficulties inherent in species identification, the ICTV Geminiviridae Study Group proposed new species demarcation criteria, the most important of which being an 89% nucleotide (nt) identity threshold between full-length DNA-A component nucleotide sequences for begomovirus species. This threshold has been utilised since with general satisfaction. More recently, an article has been published to clarify the terminology used to describe virus entities below the species level [5]. The present publication is proposing demarcation criteria and guidelines to classify and name geminiviruses below the species level. Using the Clustal V algorithm (DNAStar MegAlign software), the distribution of pairwise sequence comparisons, for pairs of sequences below the species taxonomic level, identified two peaks: one at 85-94% nt identity that is proposed to correspond to "strain" comparisons and one at 92-100% identity that corresponds to "variant" comparisons. Guidelines for descriptors for each of these levels are proposed to standardize nomenclature under the species level. In this publication we review the status of geminivirus species and strain demarcation as well as providing updated isolate descriptors for a total of 672 begomovirus isolates. As a consequence, we have revised the status of some virus isolates to classify them as "strains", whereas several others previously classified as "strains" have been upgraded to "species". In all other respects, the classification system has remained robust, and we therefore propose to continue using it. An updated list of all geminivirus isolates and a phylogenetic tree with one representative isolate per species are provided.


Subject(s)
Classification/methods , Geminiviridae/classification , Terminology as Topic , Geminiviridae/genetics , Phylogeny , Plant Diseases/virology , Plant Viruses/classification , Plant Viruses/genetics , Species Specificity
13.
Arch Virol ; 153(4): 763-81, 2008.
Article in English | MEDLINE | ID: mdl-18247103

ABSTRACT

The symptom-modulating, single-stranded DNA satellites (known as DNA-beta) associated with begomoviruses (family Geminiviridae) have proven to be widespread and important components of a large number of plant diseases across the Old World. Since they were first identified in 2000, over 260 full-length sequences (approximately 1,360 nucleotides) have been deposited with databases, and this number increases daily. This has highlighted the need for a standardised, concise and unambiguous nomenclature for these components, as well as a meaningful and robust classification system. Pairwise comparisons of all available full-length DNA-beta sequences indicate that the minimum numbers of pairs occur at a sequence identity of 78%, which we propose as the species demarcation threshold for a distinct DNA-beta. This threshold value divides the presently known DNA-beta sequences into 51 distinct satellite species. In addition, we propose a naming convention for the satellites that is based upon the system already in use for geminiviruses. This maintains, whenever possible, the association with the helper begomovirus, the disease symptoms and the host plant and provides a logical and consistent system for referring to already recognised and newly identified satellites.


Subject(s)
Begomovirus/genetics , DNA, Viral/classification , Geminiviridae/genetics , Begomovirus/classification , Classification/methods , DNA, Viral/genetics , Geminiviridae/classification , Plant Diseases/virology , Plant Viruses/classification , Plant Viruses/genetics , Species Specificity , Terminology as Topic
14.
Br J Dermatol ; 156(1): 38-44, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17199564

ABSTRACT

BACKGROUND: The vast majority of studies aimed at detecting human papillomavirus (HPV) DNA in skin cancer have used sensitive polymerase chain reaction (PCR) methods but the PCR technique, despite its high sensitivity, is not suitable to ascertain whether (i) the presence of HPV can be related only to few cells harbouring the virus, (ii) the presence of HPV is due to a tumour surface contamination and (iii) the presence of HPV is localized in cancer cells, rather than in normal keratinocytes present in the tumour biopsy. In a recent work we have found mucosal high-risk (HR) HPV genotypes in primary melanoma by PCR. OBJECTIVES: To localize mucosal HR-HPV nucleic acids and tumoural melanocytic marker in the same sections of primary melanoma samples in order to understand the relationship between HPVs and melanoma cells. METHODS: We have developed a very sensitive method that combines an enzyme-amplified fluorescent in situ hybridization (ISH) for the detection of HPV nucleic acids (types 16 and 18) with a chemiluminescent immunohistochemistry (IHC) method for the detection of the tumoural melanocytic marker HMB-45 sequentially in the same section. Digital images of fluorescent ISH and chemiluminescent IHC were separately recorded, assigned different colours and merged using specific software for image analysis. RESULTS: The combined fluorescent ISH and chemiluminescent IHC demonstrated a sharp colocalization (in the range 60-80%) of HPV nucleic acids and melanoma marker inside the same sections of melanoma biopsies, with a strong specificity and sensitivity. CONCLUSIONS: The strong colocalization of mucosal HR-HPV nucleic acids and HMB-45 melanocytic marker emphasized that viral nucleic acids were specifically present in melanoma cells and supported a possible active role of HPV in malignant melanoma.


Subject(s)
Melanoma/virology , Mouth Neoplasms/virology , Papillomavirus Infections/diagnosis , Adult , Aged , Biopsy/methods , Enzyme-Linked Immunosorbent Assay/methods , Female , Humans , Immunohistochemistry/methods , In Situ Hybridization/methods , In Situ Hybridization, Fluorescence , Luminescent Measurements , Male , Middle Aged , Mucous Membrane/virology , Papillomaviridae/isolation & purification
15.
J Med Virol ; 77(1): 102-6, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16032717

ABSTRACT

The presence and type of oncogenic papillomavirus (HPV) in classic warty/basaloid vulvar intraepithelial neoplasia and in differentiated vulvar intraepithelial neoplasia and keratinizing vulvar squamous cell carcinoma was investigated using three techniques, that is, histology, in situ hybridization, and PCR-ELISA. HPV typing was performed using in situ hybridization and PCR-ELISA. Differentiated vulvar intraepithelial neoplasia and invasive keratinizing vulvar squamous cell carcinoma proved completely negative for HPV by PCR-ELISA, in situ hybridization, and histologic examination, while in classic vulvar intraepithelial neoplasia, a HPV positivity of 66.1% was found. HPV 16 was the predominant type, with HPV 35, 33, and 52 types found rarely and sometimes together with HPV 16. PCR-ELISA proved to be the most suitable method to detect and type mucosal oncogenic HPVs. The absolute absence of HPV DNA in differentiated vulvar intraepithelial neoplasias and in keratinizing vulvar squamous cell carcinoma suggests a strong HPV-independent pathway of malignant progression to invasive carcinoma.


Subject(s)
Carcinoma, Squamous Cell/virology , Papillomaviridae/classification , Vulvar Neoplasms/virology , Adult , Aged , DNA, Viral/analysis , Enzyme-Linked Immunosorbent Assay , Epithelium/pathology , Female , Humans , Middle Aged , Papillomaviridae/genetics , Papillomaviridae/isolation & purification , Polymerase Chain Reaction
16.
Br J Dermatol ; 152(5): 909-14, 2005 May.
Article in English | MEDLINE | ID: mdl-15888145

ABSTRACT

BACKGROUND: Some studies have shown that cutaneous and mucosal melanoma biopsy specimens harbour human papillomavirus (HPV), suggesting that this virus may play a role in development and progression of the tumour. OBJECTIVES: To investigate the presence of HPV DNA and the prevalence of different high-risk mucosal HPV genotypes in primary melanoma (PM) and in acquired dysplastic melanocytic naevi (ADMN). METHODS: Fifty-one PMs from 18 men and 33 women (median age 55.5 years), 33 ADMN from 15 men and 18 women (median age 35.1 years) and 20 control skin samples from nine men and 11 women (median age 43.5 years) were studied. All diagnoses were made after histological analysis. HPV DNA analysis was made using two different polymerase chain reaction-enzyme-linked immunosorbent assay (PCR-ELISA) methods, namely MY-PCR and GP-PCR. RESULTS: Using GP-PCR, mucosal HPVs were detected in 14 PMs (27%; P = 0.0166) and eight ADMN (24%; P = 0.0367), while with MY-PCR, mucosal HPVs were found in 11 PMs (22%; P = 0.04) and five ADMN (15%; P not significant). All control skin samples were negative for mucosal HPVs with both DNA amplification procedures. CONCLUSIONS: Using our PCR-ELISA methods, the detection of mucosal high-risk HPV genotypes in 24% of precursor lesions (ADMN) and in 27% of PMs adds to the body of evidence indicating a colocalization of mucosal HPV and tumoral melanocytic pathologies.


Subject(s)
Melanoma/virology , Nevus, Pigmented/virology , Papillomaviridae/isolation & purification , Precancerous Conditions/virology , Skin Neoplasms/virology , Adolescent , Adult , Aged , Aged, 80 and over , DNA, Viral/analysis , Enzyme-Linked Immunosorbent Assay/methods , Female , Genotype , Humans , Male , Melanoma/pathology , Middle Aged , Nevus, Pigmented/pathology , Papillomaviridae/classification , Papillomaviridae/genetics , Polymerase Chain Reaction/methods , Precancerous Conditions/pathology , Skin Neoplasms/pathology
17.
Epidemiol Infect ; 132(5): 857-62, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15473148

ABSTRACT

Serum samples from 446 Italian blood donors between 18 and 65 years of age were analysed for the presence of IgG against parvovirus B19 capsid proteins VP1 and VP2 including conformational and linear epitopes. The overall prevalence of IgG against parvovirus B19 capsid proteins VP1 and VP2 against at least one antigen type was 79.1 %. No significant difference was found between men and women. In the 18-27 years age group, 77.0 % of the population had experienced infection with the virus, reaching 88.5 % in the 48-57 years age group. The overall prevalence of IgG was 78.0 % against conformational VP1 + VP2 antigens, 74.9 % against conformational VP2, 70.9 % against linear VP1 and 23.3 % against linear VP2 in the analysis of the IgG response against different conformational and linear epitopes of VP1 and VP2. Although IgG against conformational VP1+VP2, conformational VP2 and linear VP1 was present in more than 60 % of subjects in all age groups, IgG against VP2 linear antigens was present in only 32% of subjects in the 18-27 years age group and then decreased to 20.5 % in the 28-37 years age group. A different trend was noted when IgG positivity against linear and conformational epitopes was analysed separately in men and women. A significant increase was found in seroprevalence of IgG against VP2 conformational antigens with increasing age in males and a significant decrease in seroprevalence of IgG against VP2 linear antigens in women with increasing age.


Subject(s)
Antigens, Viral/immunology , Blood Donors/statistics & numerical data , Capsid Proteins/immunology , Immunoglobulin G/immunology , Parvoviridae Infections/epidemiology , Parvovirus B19, Human/immunology , Parvovirus B19, Human/isolation & purification , Adolescent , Adult , Aged , Antibodies, Viral/analysis , Female , Humans , Italy/epidemiology , Male , Middle Aged , Parvoviridae Infections/blood , Parvoviridae Infections/etiology , Parvoviridae Infections/immunology , Seroepidemiologic Studies
18.
J Med Virol ; 74(2): 272-6, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15332276

ABSTRACT

B19 virus can be transmitted by contaminated blood or blood products. Recent observations, in healthy volunteers, suggest that active B19 infection can follow the administration of plasma pools with a concentration > or =10(7) genome equivalents/ml (geq/ml) of B19 DNA. However, patients receiving batches with levels of virus DNA lower than 10(4) geq/ml do not show any evidence of transmission of the virus. The aim of the study was to show, by in vitro assays, a threshold of viral load in B19 contaminated plasma pools over which the infection can be transmitted. Twenty plasma pools, each containing 960 single donations, were tested to correlate the viral load and the level of antibodies anti-B19 with the in vitro infectivity and expression of B19 virus. All the plasma pools, titrated for B19 viral load by competitive PCR, were inoculated into KU812Ep6 erythroid human cell line. Five of the nine contaminated plasma pools, with a B19 DNA concentration > or =3.60 x 10(6) geq/ml, were able to infect KU812Ep6 cells. In vitro infectivity was shown in KU812Ep6 cells at 24 h post-infection by in situ hybridisation and amplification assays for viral DNA and RNAs. Plasma pools with a viral load in the range of 6.00 x 10(3)-8.96 x 10(4) geq/ml did not show infectivity when inoculated into KU812Ep6 cells. Medium-high titres of IgG antibodies anti-B19 were detectable in all the plasma pools and the neutralising activity associated with specific IgG anti-B19 may explain the lack of infectivity of plasma pools contaminated with a low viral load. In conclusion, in situ hybridisation and amplification assays for viral DNA and RNAs in KU812Ep6 cells inoculated with plasma pools can be valid assays to test for the presence of infectious virus in the production of B19-safe material.


Subject(s)
Blood Donors , DNA, Viral/blood , Parvoviridae Infections/virology , Parvovirus B19, Human/pathogenicity , Plasma/virology , Antibodies, Viral/analysis , Cell Line , Drug Contamination , Humans , Parvoviridae Infections/transmission , Parvovirus B19, Human/genetics , Parvovirus B19, Human/isolation & purification , Viral Load
20.
J Clin Virol ; 29(2): 137-40, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14747034

ABSTRACT

BACKGROUND AND OBJECTIVES: High-risk human papillomaviruses (HR-HPVs) are the primary cause of cervical cancer. In order to meet with clinical requirements, a direct capture test with signal amplification (HC-II), able to detect the 13 prevalent HR-HPVs, has been developed and validated for cytological specimens. STUDY DESIGN: the use of HC-II assay with formaldehyde-fixed paraffin-embedded cervical biopsies, for retrospective studies or to support histological findings, was investigated by analysing three different sample treatments. The efficacy of this test was compared with a reference PCR-ELISA, using MY09/11 and GP5+/6+ consensus primers and the use of a single extraction method for both HC-II and PCR-ELISA assays was validated. RESULTS: protease treatment of dewaxed biopsy sections allowed an optimal performance of HC-II and has also been validated for PCR-ELISA. Overall, on the analysis of 50 cervical samples HC-II and PCR-ELISA assays showed a high concordance (K=0.80). Compared with PCR-ELISA, the HC-II had a sensitivity of 86.4% and a specificity of 92.9%. The results showed that short amplimers are necessary for a sensitive PCR-ELISA from formaldehyde-fixed paraffin-embedded biopsies, while HC-II showed a relatively low sensitivity for HPV18 within the HR probe pool. CONCLUSIONS: HC-II can be a valid tool for the diagnosis of HPV infection in biopsy material. The possibility to use the same specimen preparation material for both HC-II and PCR-ELISA allows HC-II positive specimens to be further processed by PCR-ELISA if specific genotyping is needed.


Subject(s)
Cervix Uteri/virology , DNA, Viral/analysis , Nucleic Acid Hybridization/methods , Papillomaviridae/isolation & purification , Paraffin Embedding , Tissue Preservation/methods , Biopsy , Cervix Uteri/pathology , DNA, Viral/isolation & purification , Endopeptidases/metabolism , Enzyme-Linked Immunosorbent Assay , Female , Humans , Papillomavirus Infections/diagnosis , Papillomavirus Infections/virology , Polymerase Chain Reaction , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...